What Does a Sjogren’s Rash Look Like?

Sjögren’s syndrome does not produce a single, signature rash. Instead, it causes a range of skin changes that can look quite different from person to person, from persistent dry, flaky patches to purplish spots on the lower legs to ring-shaped red lesions on the face. Roughly half of people with Sjögren’s develop some form of skin involvement over the course of the disease, though estimates vary depending on how broadly “skin manifestation” is defined.¹ The three most recognized patterns are extreme dryness, vasculitis-related purpura, and annular erythema, but the full picture includes several other appearances worth knowing about, especially because skin changes sometimes show up years before the classic dry eyes and dry mouth that define the condition.

Dry Skin That Goes Beyond Ordinary Dryness

The most common and least dramatic skin finding in Sjögren’s is xerosis, a medical term for severely dry skin. Everyone’s skin gets dry from time to time, but Sjögren’s-related dryness tends to be stubborn, widespread, and resistant to ordinary moisturizers. The skin may look rough and scaly, feel tight, and crack easily. It often affects the arms, legs, and trunk. This happens because the same autoimmune process that attacks moisture-producing glands in the eyes and mouth also impairs the skin’s ability to stay hydrated. Xerosis is listed alongside vasculitis and annular erythema as one of the three most common cutaneous findings in the disease.²

Because dry skin is so common in the general population, it rarely raises alarm bells on its own. Most people who have it will never suspect an autoimmune disease, and most doctors won’t either. But when dryness is extreme, doesn’t respond to emollients, and comes alongside dry eyes, a persistently dry mouth, joint pain, or fatigue, it becomes a useful clue.

Purpura and Vasculitis on the Lower Legs

The skin finding that carries the most clinical weight in Sjögren’s is cutaneous vasculitis, which shows up in roughly one in ten people with primary Sjögren’s.³ Vasculitis means inflammation of the blood vessels, and in Sjögren’s it almost always targets the small vessels in the skin, particularly in the lower legs.

What you actually see depends on severity. The hallmark is palpable purpura: small, raised, reddish-purple spots that don’t fade when you press on them. They can be as small as a pinhead or merge into larger patches. They tend to cluster from the ankles up to the knees. In a study of 38 patients with Sjögren’s-related vasculitis, 95% had small-vessel disease and it presented as palpable purpura, urticarial lesions, or reddish raised bumps.⁴ In more severe cases, the lesions can blister or ulcerate, leaving behind dark spots of post-inflammatory hyperpigmentation after they heal.

This is more than a cosmetic issue. Purpura in Sjögren’s signals that the immune system is attacking blood vessels, and that process isn’t always limited to the skin. In the same study, systemic involvement beyond the skin was found in nearly half of the patients with vasculitis, and about a third had cryoglobulins, abnormal proteins in the blood that clump in the cold and drive more aggressive vascular damage.⁴ When cryoglobulinemic vasculitis develops in Sjögren’s, purpura is the most common presentation, appearing in about 90% of affected patients.⁵

Annular Erythema and Ring-Shaped Lesions

Annular erythema is a distinctive rash that looks like red or pink rings on the skin, often with a paler center. The rings can range from coin-sized to several inches across, and they may overlap or merge into polycyclic (figure-eight or paisley-like) shapes. They appear most often on the face and upper arms, and the borders can be flat, slightly raised, or occasionally scaly.⁶

In a study of 22 patients with Sjögren’s-associated annular erythema, the rash fell into three visual patterns. Most had lesions with a raised, swollen-looking border, somewhat resembling Sweet syndrome. A smaller group had scaly-edged rings that closely mimicked subacute cutaneous lupus. A few had a more papular (bumpy) form.⁶ This variety is one reason the rash is easy to misdiagnose. A dermatologist unfamiliar with Sjögren’s skin involvement might attribute it to lupus, fungal infection, or drug reaction.

Annular erythema affects a minority of Sjögren’s patients, roughly 9% by one estimate.⁷ But it’s an important finding because it can be the first visible sign of the disease. In a study of 43 non-Asian patients with Sjögren’s-related annular erythema, all reported photosensitivity, and 93% said their skin flares were worst during the warmer months.⁸ That seasonal pattern and sun sensitivity is a practical tip for recognizing the condition: if you develop ring-shaped red lesions that worsen in spring and summer, Sjögren’s should be on the list of possibilities.

Urticarial Lesions That Aren’t Really Hives

Some people with Sjögren’s develop raised, red welts that look nearly identical to ordinary hives (urticaria). The difference is in how they behave. Regular hives are fleeting; a single welt usually appears, itches intensely, and fades within a day, leaving no trace. Urticarial vasculitis lesions, which occur in Sjögren’s, last longer than 24 hours in the same spot, tend to burn or sting more than they itch, and often leave behind bruising or brownish discoloration after they resolve.⁹

Urticarial vasculitis in Sjögren’s may also be accompanied by joint pain, fatigue, or low-grade fever, symptoms that ordinary hives typically don’t cause. Purpura and urticaria-like lesions were actually the two most frequent skin findings in one classic study of primary Sjögren’s patients with vasculitis, and both were tied to inflammation of small blood vessels in the skin.¹⁰ If antihistamines don’t clear your “hives” within a day or two, or if you notice bruise-like marks after the welts go down, that warrants a closer look.

The Photosensitivity Connection

Sun sensitivity is a feature that ties several of these skin findings together. Many Sjögren’s patients notice that their rashes flare or first appear after UV exposure. Research using controlled UV light exposure has confirmed that photosensitivity is a real, measurable phenomenon in certain Sjögren’s patients, and that ultraviolet light plays a direct role in triggering annular erythema. The underlying mechanism appears to be distinct from the photosensitivity seen in lupus, even though the two can look strikingly similar on the skin.¹¹

For practical purposes, this means sun protection matters. If you have Sjögren’s and notice red or ring-shaped rashes developing on sun-exposed areas like the face, neck, or arms, especially during warm months, broad-spectrum sunscreen and protective clothing can help reduce flares. This is true regardless of whether your dermatologist calls the rash annular erythema, subacute cutaneous lupus-like, or something else.

How to Tell Sjögren’s Skin Changes from Lupus

This is a genuinely difficult clinical question, and not just for patients. Even experienced dermatologists can struggle with it. Sjögren’s and lupus share anti-Ro/SSA antibodies, overlap immunologically, and can produce nearly identical-looking ring-shaped rashes on the face and arms. Some patients carry features of both diseases simultaneously, and the diagnostic overlap is one of the more confusing areas in rheumatology. In fact, subacute cutaneous lupus erythematosus, purpura, and livedo reticularis (a lace-like purple discoloration of the skin) are specifically listed among the features that make Sjögren’s hardest to distinguish from lupus.¹²

A few clues can help tilt the balance. Lupus butterfly rashes tend to spare the nasolabial folds (the creases running from the nose to the corners of the mouth) and often have a sun-exposed distribution. Sjögren’s annular erythema can also appear on the face but usually forms distinct rings rather than a solid flush. Sjögren’s vasculitis tends to favor the lower legs, while lupus skin involvement often targets the face, scalp, and hands. A biopsy can sometimes distinguish the two: Sjögren’s vasculitis typically shows deep clusters of immune cells around blood vessels and glands, while lupus tends to produce more changes at the surface of the skin.⁶ But the truth is, in many patients, the distinction requires blood work, clinical history, and specialist judgment.

The Role of Anti-Ro/SSA Antibodies

One pattern that helps explain who gets skin involvement is the presence of anti-Ro/SSA antibodies. These are among the most characteristic autoantibodies in Sjögren’s, and they show up disproportionately in patients with skin disease. In one landmark study, 84% of primary Sjögren’s patients who had vasculitis also carried anti-Ro/SSA antibodies.¹⁰ Studies of sun-sensitive patients across autoimmune conditions have found that anti-Ro52 antibody levels are highest in those with primary Sjögren’s.¹³

This doesn’t mean that every Sjögren’s patient with positive anti-Ro antibodies will develop a rash, or that those without the antibodies are immune to skin problems. But if you already know you carry these antibodies, it’s worth paying attention to new or persistent skin changes and mentioning them to your rheumatologist. The antibody profile can also help your care team decide whether a suspicious rash is more likely Sjögren’s-related or something else entirely.

Raynaud’s Phenomenon and Skin Color Changes

Raynaud’s phenomenon, where the fingers (and sometimes toes) turn white, then blue, then red in response to cold or stress, isn’t a rash in the traditional sense, but it’s a visible skin change that about 13% of people with primary Sjögren’s experience.¹⁴ In nearly half of those patients, Raynaud’s was the first autoimmune symptom to appear, sometimes years before dry eyes or dry mouth developed.¹⁴

Sjögren’s patients with Raynaud’s appear to have a more immunologically active form of the disease, with higher levels of certain inflammatory markers and a greater likelihood of other extraglandular features like low white cell counts and thyroid inflammation.¹⁵ Cold exposure was the trigger in all patients in the study mentioned above, while emotional stress provoked episodes in about a third. If you experience unexplained Raynaud’s alongside dryness, it’s a combination that should prompt autoimmune testing.

Why Skin Findings Matter Beyond Appearance

For many people with Sjögren’s, the skin changes are cosmetically frustrating but medically manageable. For some, though, they serve as an early warning of more serious systemic disease. Cutaneous vasculitis in particular has been linked to a higher risk of lymphoma. A 2025 study comparing Sjögren’s patients with and without vasculitis found that 13% of those with vasculitis developed lymphoma, compared to 4% of matched controls without vasculitis.¹⁶ Vasculitis associated with cryoglobulins carries a particularly poor prognosis, with a higher rate of severe systemic involvement and an established association with B-cell lymphoma.³

This doesn’t mean every purple spot on your leg is a lymphoma warning sign. Most Sjögren’s-related skin changes are benign and respond to treatment. But recurrent or worsening purpura, especially on the lower legs, is something to track and report to your rheumatologist rather than dismiss as a bruise.

When Skin Signs Come Before Diagnosis

One of the more frustrating aspects of Sjögren’s is that skin involvement can appear long before the disease is recognized. In about 85% of cases, cutaneous vasculitis actually appears before the onset of classic sicca (dryness) symptoms.³ Similarly, cryoglobulinemic vasculitis presented at or near disease onset in 39% of one cohort.⁵ This means people can spend months or years seeing dermatologists for unexplained purpura, ring-shaped rashes, or persistent hives before anyone connects the dots to an underlying autoimmune condition.

This pattern is even more pronounced in children. In a study of juvenile primary Sjögren’s with skin involvement, nearly 90% of affected children had cutaneous lesions as their very first symptom, with a median delay of 12 months before Sjögren’s was diagnosed. Palpable purpura was the most common skin finding in these children, followed by urticarial lesions.¹⁷ Sjögren’s is rare in children, so pediatric dermatologists may not think to screen for it, leading to longer diagnostic delays.

Treatment of Sjögren’s Skin Manifestations

Treating the skin component of Sjögren’s depends on what type of skin involvement you have. For dry skin alone, the approach is aggressive moisturizing: thick emollients, gentle cleansers, and avoiding hot water that strips oils from the skin. For inflammatory skin manifestations like annular erythema and vasculitis, systemic medications are usually needed.

Hydroxychloroquine has emerged as a first-line treatment for annular erythema in Sjögren’s. In a study of 16 patients, hydroxychloroquine reduced the severity of annular erythema lesions by about 86% over 12 weeks, and 60% of patients with face-only disease achieved complete remission within just four weeks.¹⁸ The drug also helped patients who had been on long-term steroids taper their dose, which is valuable given the well-known side effects of prolonged steroid use.¹⁸

Vasculitis-related skin disease can be harder to control. In one case of aggressive, ulcerating purpura, the patient failed to improve after nearly six months on prednisone and methotrexate, with ongoing skin breakdown and new lesions appearing on her arms. Switching to hydroxychloroquine cleared the active lesions within five months, leaving only residual dark discoloration where the purpura had been.¹⁹ That case is a single patient, not a clinical trial, but it illustrates an important point: the standard immunosuppressive playbook doesn’t always work for Sjögren’s skin disease, and hydroxychloroquine is often worth trying even when other drugs have failed.

For vasculitis driven by cryoglobulins, treatment typically involves more aggressive immunosuppression, and management of the cryoglobulinemia itself. These patients often need close monitoring for lymphoma development, given the established link between cryoglobulinemic vasculitis and B-cell malignancy.

What a Biopsy Shows

If your doctor suspects Sjögren’s-related skin disease, a skin biopsy can help confirm it and rule out other causes. Under the microscope, two main patterns have been described. One involves neutrophils (a type of white blood cell) clustering around and damaging small blood vessel walls, with fragments of dying neutrophils and fibrin deposited along the vessel lining. The other pattern involves a quieter infiltration of immune cells, primarily lymphocytes, surrounding the vessels without the dramatic destruction seen in the first type.²⁰ In annular erythema specifically, biopsies tend to show deep clusters of lymphocytes around blood vessels and around skin appendages like hair follicles and sweat glands, with relatively little disruption at the skin surface.⁶

The biopsy findings won’t always give a definitive answer on their own. But combined with blood work showing anti-Ro/SSA antibodies and clinical symptoms of dryness, they can help solidify a diagnosis, especially in patients whose rash appeared before the classic glandular symptoms and who may have been bouncing between specialists without a unifying explanation.

Sjögren’s Skin Findings in Children

Sjögren’s is overwhelmingly a disease of middle-aged and older adults, and most of the skin literature reflects that. When it does appear in children, the picture can look somewhat different. In a pediatric cohort, palpable purpura accounted for about 63% of skin manifestations, followed by urticarial lesions at about 26% and dry skin at roughly 11%. Other findings included skin ulcers, erythema nodosum (tender red bumps usually on the shins), and livedo reticularis.¹⁷ The cutaneous domain was among the most commonly involved in a separate pediatric series as well.²¹

What stands out in the pediatric data is the relative prominence of purpura and vascular findings compared to the dry skin that dominates the adult picture. A child with recurrent unexplained purpura, especially if paired with enlarged salivary glands or subtle dryness complaints, deserves evaluation for Sjögren’s, even though the disease is uncommon in that age group.

1
PubMed. Dermatologic manifestations of Sjögren syndrome
2
Oxford Textbook of Sjögren’s Syndrome. Cutaneous involvement and management of Sjögren’s syndrome
3
Anais Brasileiros de Dermatologia. Skin manifestations associated with systemic diseases – Part I – Section: Sjogren’s syndrome
4
Medicine. Cutaneous Vasculitis in Primary Sjögren Syndrome
5
PubMed. Cryoglobulinemic vasculitis in primary Sjögren’s Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease
6
PubMed. Annular erythema. A comparative study of Sjögren syndrome with subacute cutaneous lupus erythematosus
7
PubMed Central. Sjögren’s Syndrome with Lichen Sclerosus: A Case Report
8
PubMed. Annular erythema in primary Sjogren’s syndrome: description of 43 non-Asian cases
9
PubMed. Urticarial lesions: if not urticaria, what else? The differential diagnosis of urticaria: part II. Systemic diseases
10
PubMed. Cutaneous manifestations of primary Sjögren’s syndrome: a reflection of vasculitis and association with anti-Ro(SSA) antibodies
11
PubMed. Photoprovocation test and immunohistochemical analysis of inducible nitric oxide synthase expression in patients with Sjögren’s syndrome associated with photosensitivity
12
Seminars in Arthritis and Rheumatism. The Overlap of Sjögren’s Syndrome with Other Systemic Autoimmune Diseases
13
PubMed. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun
14
The Journal of Rheumatology. Raynaud’s phenomenon in primary Sjögren’s syndrome. Prevalence and clinical characteristics in a series of 320 patients
15
PubMed. Interferon-gamma is increased in patients with primary Sjogren’s syndrome and Raynaud’s phenomenon
16
JAMA Dermatology. Cutaneous Vasculitis in Primary Sjögren Disease
17
PubMed. Juvenile primary Sjogren’s syndrome with cutaneous involvement
18
PubMed. Efficacy of hydroxychloroquine for treating annular erythema associated with Sjögren’s syndrome
19
PubMed Central. Cutaneous purpura of Sjögren syndrome successfully treated with hydroxychloroquine
20
PubMed Central. Skin Findings in a Patient with Sjogren’s Syndrome
21
PubMed Central. A single-center study of clinical features of pediatric Sjögren’s syndrome